Blb&B Advisors, LLC Biogen Inc. Transaction History

Blb&B Advisors, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$193.77 - $244.14 $163,348 - $205,810	-843 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$223.92 - $287.77 $44,784 - $57,554	-200 Reduced 19.18%	843 $202,000
Q3 2021 Oct 19, 2021	BUY	$282.99 - $369.05 $56,598 - $73,810	200 Added 23.72%	1,043 $295,000
Q2 2021 Jul 20, 2021	SELL	$259.0 - $414.71 $259 - $414	-1 Reduced 0.12%	843 $292,000
Q1 2021 Apr 19, 2021	SELL	$242.95 - $284.63 $52,234 - $61,195	-215 Reduced 20.3%	844 $236,000
Q4 2020 Jan 19, 2021	BUY	$236.26 - $355.63 $17,719 - $26,672	75 Added 7.62%	1,059 $259,000
Q2 2020 Jul 16, 2020	SELL	$258.66 - $342.55 $11,381 - $15,072	-44 Reduced 4.28%	984 $263,000
Q4 2019 Jan 21, 2020	SELL	$220.06 - $304.07 $39,610 - $54,732	-180 Reduced 14.9%	1,028 $305,000
Q2 2019 Jul 29, 2019	BUY	$219.29 - $241.72 $264,902 - $291,997	1,208 New	1,208 $283,000
Q1 2019 Apr 19, 2019	SELL	$216.71 - $338.96 $258,968 - $405,057	-1,195 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$278.5 - $352.75 $49,573 - $62,789	-178 Reduced 12.96%	1,195 $360,000
Q3 2018 Oct 12, 2018	BUY	$293.51 - $383.83 $17,023 - $22,262	58 Added 4.41%	1,373 $485,000
Q2 2018 Jul 11, 2018	SELL	$257.52 - $306.91 $12,876 - $15,345	-50 Reduced 3.66%	1,315 $382,000
Q1 2018 Apr 09, 2018	BUY	$260.13 - $367.91 $24,712 - $34,951	95 Added 7.48%	1,365 $374,000
Q4 2017 Jan 16, 2018	BUY	$307.64 - $344.58 $19,996 - $22,397	65 Added 5.39%	1,270 $405,000
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $338,785 - $397,276	1,205	1,205 $377,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Blb&B Advisors, LLC with notifications on news.